Cargando…
Circulating microparticles: square the circle
BACKGROUND: The present review summarizes current knowledge about microparticles (MPs) and provides a systematic overview of last 20 years of research on circulating MPs, with particular focus on their clinical relevance. RESULTS: MPs are a heterogeneous population of cell-derived vesicles, with siz...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651414/ https://www.ncbi.nlm.nih.gov/pubmed/23607880 http://dx.doi.org/10.1186/1471-2121-14-23 |
_version_ | 1782269224972976128 |
---|---|
author | Barteneva, Natasha S Fasler-Kan, Elizaveta Bernimoulin, Michael Stern, Joel NH Ponomarev, Eugeny D Duckett, Larry Vorobjev, Ivan A |
author_facet | Barteneva, Natasha S Fasler-Kan, Elizaveta Bernimoulin, Michael Stern, Joel NH Ponomarev, Eugeny D Duckett, Larry Vorobjev, Ivan A |
author_sort | Barteneva, Natasha S |
collection | PubMed |
description | BACKGROUND: The present review summarizes current knowledge about microparticles (MPs) and provides a systematic overview of last 20 years of research on circulating MPs, with particular focus on their clinical relevance. RESULTS: MPs are a heterogeneous population of cell-derived vesicles, with sizes ranging between 50 and 1000 nm. MPs are capable of transferring peptides, proteins, lipid components, microRNA, mRNA, and DNA from one cell to another without direct cell-to-cell contact. Growing evidence suggests that MPs present in peripheral blood and body fluids contribute to the development and progression of cancer, and are of pathophysiological relevance for autoimmune, inflammatory, infectious, cardiovascular, hematological, and other diseases. MPs have large diagnostic potential as biomarkers; however, due to current technological limitations in purification of MPs and an absence of standardized methods of MP detection, challenges remain in validating the potential of MPs as a non-invasive and early diagnostic platform. CONCLUSIONS: Improvements in the effective deciphering of MP molecular signatures will be critical not only for diagnostics, but also for the evaluation of treatment regimens and predicting disease outcomes. |
format | Online Article Text |
id | pubmed-3651414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36514142013-05-11 Circulating microparticles: square the circle Barteneva, Natasha S Fasler-Kan, Elizaveta Bernimoulin, Michael Stern, Joel NH Ponomarev, Eugeny D Duckett, Larry Vorobjev, Ivan A BMC Cell Biol Review BACKGROUND: The present review summarizes current knowledge about microparticles (MPs) and provides a systematic overview of last 20 years of research on circulating MPs, with particular focus on their clinical relevance. RESULTS: MPs are a heterogeneous population of cell-derived vesicles, with sizes ranging between 50 and 1000 nm. MPs are capable of transferring peptides, proteins, lipid components, microRNA, mRNA, and DNA from one cell to another without direct cell-to-cell contact. Growing evidence suggests that MPs present in peripheral blood and body fluids contribute to the development and progression of cancer, and are of pathophysiological relevance for autoimmune, inflammatory, infectious, cardiovascular, hematological, and other diseases. MPs have large diagnostic potential as biomarkers; however, due to current technological limitations in purification of MPs and an absence of standardized methods of MP detection, challenges remain in validating the potential of MPs as a non-invasive and early diagnostic platform. CONCLUSIONS: Improvements in the effective deciphering of MP molecular signatures will be critical not only for diagnostics, but also for the evaluation of treatment regimens and predicting disease outcomes. BioMed Central 2013-04-22 /pmc/articles/PMC3651414/ /pubmed/23607880 http://dx.doi.org/10.1186/1471-2121-14-23 Text en Copyright © 2013 Barteneva et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Barteneva, Natasha S Fasler-Kan, Elizaveta Bernimoulin, Michael Stern, Joel NH Ponomarev, Eugeny D Duckett, Larry Vorobjev, Ivan A Circulating microparticles: square the circle |
title | Circulating microparticles: square the circle |
title_full | Circulating microparticles: square the circle |
title_fullStr | Circulating microparticles: square the circle |
title_full_unstemmed | Circulating microparticles: square the circle |
title_short | Circulating microparticles: square the circle |
title_sort | circulating microparticles: square the circle |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651414/ https://www.ncbi.nlm.nih.gov/pubmed/23607880 http://dx.doi.org/10.1186/1471-2121-14-23 |
work_keys_str_mv | AT bartenevanatashas circulatingmicroparticlessquarethecircle AT faslerkanelizaveta circulatingmicroparticlessquarethecircle AT bernimoulinmichael circulatingmicroparticlessquarethecircle AT sternjoelnh circulatingmicroparticlessquarethecircle AT ponomareveugenyd circulatingmicroparticlessquarethecircle AT duckettlarry circulatingmicroparticlessquarethecircle AT vorobjevivana circulatingmicroparticlessquarethecircle |